Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Oregon Health and Science University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of branch or central retinal vein occlusion
You may not be if
Inability to give informed consent
Inability to complete study tests within a 30 day period from date of enrollment
Significant renal disease, defined as a history of chronic renal failure requiring dialysis or kidney transplant
A prior history of reaction to fluorescein or other dyes.
A condition that, in the opinion of the investigator, would preclude participation in the study (e.g., unstable medical status including blood pressure, cardiovascular disease, and glycemic control).
Blood pressure \> 180/110 (systolic above 180 OR diastolic above 110). If blood pressure is brought below 180/110 by anti-hypertensive treatment, subject can become eligible.
Systemic anti-VEGF or pro-VEGF treatment within 4 months prior to treatment.
Women of child-bearing potential: pregnant or lactating or intending to become pregnant within the next 12 months due to unknown safety of fluorescein angiography.
Prior PRP or focal laser that would alter the macular perfusion and retino-vascular features.
Inability to maintain fixation for OCT imaging.
Other ocular condition is present such that, in the opinion of the investigator, may alter the retinal perfusion.
An ocular condition is present that, in the opinion of the investigator, might affect or alter visual acuity during the course of the study (e.g., cataract).
Substantial cataract that, in the opinion of the investigator, is likely to decrease visual acuity by 3 lines or more (i.e., cataract would be reducing acuity to 20/40 or worse if the eye was otherwise normal).
Media opacity or otherwise that would prevent either fixation or ability to obtain adequate images as determined by the examiner.
History of major ocular surgeries (including vitrectomy, cataract extraction, scleral buckle, any intraocular surgery, etc.) within 4 months prior to enrollment.
